Survey reveals strong public desire for notification about AI use in healthcare

Over 60% of adults value being notified about AI in healthcare, underscoring the importance of transparency and ethical considerations in health systems.

Schwazze Q1 Revenue Was Flat From Q4 at $40 Million

Schwazze Announces First Quarter 2023 Financial Results Revenue Increases 26% to $40.0M Compared to $31.8M in Q1 2022 Income From Operations Grew to $5.6M Compared to ($4.8M) in Q1 2022 Adjusted

May 11, 2023

What we’re starting to learn about H5N1 in cows, and the risk to people

The H5N1 bird flu virus has been around for decades, and the damage it wreaks on chickens and other poultry is well documented. But the

April 30, 2024

Florida CNS gene therapy biotech shuts down

Seven-year-old gene therapy startup Lacerta Therapeutics has folded and sold its assets, a board member confirmed to Endpoints News. The University of Florida spinout, based

August 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.